We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AMRI Appoints Dr. Michael A. Guaciaro to Lead New Division

News   Mar 02, 2006

 
AMRI Appoints Dr. Michael A. Guaciaro to Lead New Division
 
 
 

RELATED ARTICLES

Designing “Smart” Drugs to Prevent Malaria Treatment Resistance

News

Researchers at the Crick and Imperial College London have generated malaria parasites resistant to a promising new class of candidate antimalarial drugs. By analyzing the structural changes behind the resistance, they identified novel compounds that were immune to this mechanism of resistance.

READ MORE

Targeting Ribosome Biogenesis as a Novel Approach for Multi-Stage Cancer Treatment

News

Nearly ninety per cent of all cancer patient deaths are due to metastasis. A study shows that a process that allows the cells to metastasise is aided by the synthesis of new ribosomes, the cell components in which proteins are produced.

READ MORE

Designer Drugs to Inhibit Hepatitis A Virus

News

Structure-based drug design revealed that a compound previously investigated for the treatment of head-and-neck cancer could function as a lead compound for the development of drugs to treat hepatitis A virus infection.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE